MedTrace Logo

Effect of B. Longum 1714™ on Sleep Quality

NCT04167475 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2020-06-30

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of supplementation with the B. longum 1714™ strain on subjective and objective sleep quality in healthy participants.

Conditions

  • Subjective Sleep Quality
  • Objective Sleep Quality

Interventions

DIETARY_SUPPLEMENT

Probiotic capsule

Each probiotic capsule contains 1 x 10\^9 CFU B. longum 1714™ with corn starch and magnesium stearate. The probiotic capsules will be supplied by PrecisionBiotics Ltd.

DIETARY_SUPPLEMENT

Placebo capsule

Each placebo capsule contains corn starch and magnesium stearate. The placebo capsules will be supplied by PrecisionBiotics Ltd.

Sponsors & Collaborators

  • Nottingham Trent University

    collaborator OTHER

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY

  • PrecisionBiotics Group Ltd.

    lead INDUSTRY

Principal Investigators

  • Eileen Murphy, PhD · PrecisionBiotics Group Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2020-04-03
Completion
2020-06-23

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167475 on ClinicalTrials.gov